Scientist and entrepreneur, Dr. K Anji Reddy establishes Dr. Reddy's Laboratories with a vision of making medicines accessible to the millions in India. The company begins by making the active ingredient Methyldopa – a hypertension drug that was unavailable in India until 1985. We supply Methyldopa to Merck, Sharp, Dohme Corp, manufacturers of Aldomet, and export it to West Germany, Yugoslavia, Bangladesh, Kenya and Canada. On the back of its success with active ingredients, Dr Reddy’s begins developing formulations. By 1990, Dr. Reddy’s is the first Indian pharma company to export Norfloxacin and Ciprofloxacin to Europe and Far East.